ODI Pharma AB (publ) (NGM:ODI)
Sweden · Delayed Price · Currency is SEK 4.120
-0.040 (-0.96%)
At close: Mar 20, 2026
ODI Pharma AB Revenue
ODI Pharma AB had revenue of 10.93M SEK in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 20.04M, down -6.80% year-over-year. In the fiscal year ending June 30, 2025, ODI Pharma AB had annual revenue of 3.13M, down -85.94%.
Revenue (ttm)
20.04M
Revenue Growth
-6.80%
P/S Ratio
3.77
Revenue / Employee
20.04M
Employees
1
Market Cap
75.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.13M | -19.15M | -85.94% |
| Jun 30, 2024 | 22.29M | 22.15M | 15,880.34% |
| Jun 30, 2023 | 139.46K | -173.48K | -55.44% |
| Jun 30, 2022 | 312.94K | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valuno Group AB | 2.19B |
| NGS Group AB | 285.72M |
| Lohilo Foods AB | 186.79M |
| Spotlight Group AB | 114.42M |
| ABAS Protect AB | 88.42M |
| Mediacle Group AB | 47.49M |
| Amido AB | 44.95M |
| Ramlösa shipping AB | 39.45M |